Glecaprevir/Pibrentasvir therapy is effective in treating acute hepatitis C virus infection
Stanislas Ball, M.D., Ph.D. Image source: APHC Eight weeks of glecaprevir/pibrentasvir (G/P) in adults and adolescents with previously untreated acute hepatitis C virus (HCV) infection, according to a study presented at the AMA Liver Meeting 2023 Treatment sessions are a safe and effective method of … Read more